Tetravalent dengue virus vaccine (National Institutes of Health)

N/A

Report date: 2025/02/06 20:00:06

Base Information

Drug NameTetravalent dengue virus vaccine (National Institutes of Health)
Drug Alias NameTetraVax-DVTV-005TV-003
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsZika Virus InfectionDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstituto Butantan
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesMedigen Vaccine Biologics Corp
Active IndicationsZika Virus Infection
Inactive IndicationsDengue

Other Information

ATC CodeN/A
Related LinksN/A